期刊文献+

米诺地尔脂质体制剂与普通制剂对C57BL/6小鼠毛囊VEGF表达影响的对比研究 被引量:1

Change of Vascular Endothelial Growth Factor resulted by different Minoxidil praeparatums in C57BL/6 Mouse
下载PDF
导出
摘要 目的:探讨米诺地尔脂质体制剂与普通制剂对C57BL/6小鼠毛囊VEGF表达的影响。方法:将C57BL/6小鼠随机分组,在背部涂抹两种制剂的米诺地尔,通过小鼠皮色变化以及组织学特征对毛囊进行分期,并采用了数码照相和ImageProPlus图像分析处理系统相结合的方法对小鼠涂药部位VEGF表达进行分析。结果:米诺地尔各组小鼠毛囊从休止期转变为生长期,并且处于生长期毛囊VEGF表达阳性部位较多,而1.4%脂质体米诺地尔组较1.4%米诺地尔普通制剂组效果更显著。结论:实验结果表明米诺地尔可增强VEGF表达,而脂质体制剂较普通制剂效果更为显著。 Objective To study the change of vascular endothelial growth factor resulted by different minoxidil praeparatums in the hair follicle of C57BL/6 Mice. Methods The C57BL/6 mice were divided into 4 groups. The minoxidil with two dosage forms were applied to the back skin of mice. The anagen onset and its duration were evaluated by the skin color and histologic characteristics. The state of vascular endothelial growth factor (VEGF) expression in the skin of C57BL/6 mice was investigated by means of immunohistochemistry and image analysis technique. Results All minoxidil groups induced the anagen onset, But 1.4% lipo-minoxidil group had a higher expression of VEGF than 1.4% minoxidil group. Conclusion These findings indicate that lipo-minoxidil have a more significant promote on the VEGF expression than the common praeparatum.
出处 《中国美容医学》 CAS 2006年第3期250-252,i0001,共4页 Chinese Journal of Aesthetic Medicine
关键词 血管内皮生长因子 脂质体米诺地尔 毛囊 VEGF lipo-minoxidil hair follicle
  • 相关文献

参考文献7

  • 1Leung DW,Cachianes G,Kuang WJ,et al.Vascular endothelial growth factor is a secreted angiogenic mitogen[J].Science,1989,246(4935):13062.
  • 2Takeshita S,PuL Q,Steinl A,et al.Intra muscular administrationof vascular endothelial growth factor induced dose-dependent collater alartery augmentation ina rabbit model of chronic limbis chemia[J].Circulation,1994,90(pt2):228.
  • 3Kishimao J,Ehama R,Ge Y,et al.In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin[J].Am J Pathol,2000,157:103-110.
  • 4杨壮群,屠军波,姚天华,赵小鸽.NGF与雌激素对离体培养的人头皮毛囊影响的实验研究[J].中华整形外科杂志,2004,20(1):48-50. 被引量:13
  • 5屠军波,王九成,杨壮群,贺西京,付经国,陈涛.脂质体透皮吸收与靶向毛囊的研究进展[J].中华整形外科杂志,2005,21(3):225-227. 被引量:6
  • 6Goldman CK,Tsai J,Soroceanu L,et al.Loss of vascular endothelial growth factor in human alopecia hair follicle[J].J Invest Dermatol,1995(suppl),104:18-20.
  • 7Lachgar S,Charveron M,Gall Y,et al.Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells[J].Br J Dermatol,1998,138:407-411.

二级参考文献26

  • 1Agarwal R, Katare OP, Vyas SP. The pilosebaceous unit: a pivotal route for topical drug delivery. Methods Find Exp Clin Pharmacol,2000,22:129-133.
  • 2JA Bouwstra, PL Honeywell-Nguyen. Skin structure and mode of action of vesicles. Advanced Drug Delivery Reviews, 2002,S41-S55.
  • 3Betz, G Imboden R, Imanidis G. Interaction of liposome formulations with human skin in vitro. Int J Pharm, 2001,229:117-129.
  • 4Ciotti SN, Weiner N. Follicular liposomal delivery systems. J Liposome Res, 2002,12:143-148.
  • 5Valenta C, Janisch M. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int J Pharm,2003,258:133-139.
  • 6Ogiso T, Yamaguchi T, Iwaki M, et al. Effect of positively and negatively charged liposomes on skin permeation of drugs. J Drug Target, 2001,9: 49-59.
  • 7El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm,2000, 25,204(1-2): 159-169.
  • 8Verma DD, Verma S, Blume G, et al. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm, 2003,258:: 145-151.
  • 9Kirjavainen M, Urtti A,Valjakka-Koskela R. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci,1999,7: 279-286.
  • 10Katahira N, Murakami T, Kugai S, et al. Enhancement of topical delivery of alipophilic drug from charged multilamellar liposomes. J Drug Target, 1999,6:405-409.

共引文献17

同被引文献12

  • 1陈声利,孙建方.米诺地尔治疗脱发的药理与临床研究[J].国外医学(皮肤性病学分册),2004,30(5):276-278. 被引量:59
  • 2Mura S, Pirot F.Liposomes and niosomes as potential carriers for dermal delivery of minoxidil[J].J Drug Target,2007,15 (2): 101-108.
  • 3Hasanovic A, Hollick C Improvement in pttysicochemical parameters of DPPC liposomes and increase in skin permeation of aciclovir and minoxidil by the addition of cationic polymers [J].Eur J Pharm Biopharm,2010,75(2): 148-153.
  • 4Jain B,Singh B.Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units[J].J Liposome Res, 2010,20(2): 105-114.
  • 5Radtken,Miiller RH NLCTM.Nanostructured lipid Carriers the new gene ration of lipid drug carrier[J].New Drugs,2001,2:48-52.
  • 6Mu ller RH, Petersen RD, Hommoss A,et al. Nanostructured lipid carriers (NLC) in cosmetic dermal products[J].Adv Drug Deliv Rev, 2007,59(6):522-530.
  • 7Muller RH,Radtke M,Wissing SA.Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations [J].Adv Drug Deliv Rev, 2002, 54 (Suppl): S131-S155.
  • 8Muller RH,Radtke M,Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs [J]. Int J Pharm,2002,242 (1-2):121-128.
  • 9Friedman ES,Friedman PM,Cohen DE,et al.Allergic contact dermatitis to topical minoxidil solution:etiology and treatment [J].J Am Acad Dermatol,2002,46:309-312.
  • 10JiHH, Sh SK, JinHC,et al. Effect ofminoxidil on proliferation and apoptosis in dermal papilla cells othuman hair follicle[J].J Dermatol Sci,2004,34:91-98.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部